Jonathan F. Anker, Jennifer King, Abhishek Tripathi, Sudeh Izadmehr, Neda Hashemi-Sadraei, Sumanta Kumar Pal, Tareq Salous, Qianqian Zhao, Menggang Yu, Danielle Afterman, Eric James Miller, Erin Heath, Margarita Rivera, Muna Gure, Rachel Brody, Kevin G. Chan, Hristos Z. Kaimakliotis, Reza Mehrazin, John Sfakianos, Matthew D. Galsky. "Phase 2 trial of pembrolizumab (P) with response-guided bladder-sparing in patients with muscle-invasive bladder cancer (MIBC; HCRN GU 20-444).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.737